Literature DB >> 6253392

Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system.

H D Perez, B B Weksler, I M Goldstein.   

Abstract

Certain products of arachidonic acid have been demonstrated recently to possess chemotactic activity for human polymorphonuclear leukocytes (PMN). Enzymatic (lipoxygenase, cyclooxygenase) generation of these lipid chemotaxins proceeds through the formation of intermediate lipid peroxides. Since lipid peroxidation can be mediated by oxygen-derived free radicals, we have examined whether chemotactically active products of arachidonic acid could be produced by exposing this unsaturated fatty acid to a superoxide-generating system. A lipid with potent chemotactic activity for human PMN was produced by incubating arachidonic acid with xanthine oxidase and acetaldehyde. Generation of chemotactic activity was time-dependent and could be inhibited to the greatest extent by scavengers of singlet oxygen (i.e., histidine, uric acid, and 2,5-dimethylfuran). Inhibition was also observed with scavengers of superoxide anion radicals (i.e., superoxide dismutase), hydrogen peroxide (i.e., catalase), and hydroxyl radicals (i.e., mannitol). Silica gel thin-layer radiochromatography demonstrated a single peak with chemotactic activity (Rf = 0.33-0.38) distinct from unaltered arachidonic acid. The product of arachidonic acid was chemotactic at a concentration of 3.0 ng/ml and chemokinetic at concentrations of 0.75-1.5 ng/ml. Since PMN produce oxygen-derived free radicals and singlet oxygen upon stimulation of their plasma membrane, and since arachidonic acid is widely distributed in human tissues, free radical-mediated generations of chemotactic activity from arachidonic acid may play an important role in amplifying inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253392     DOI: 10.1007/bf00915032

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  39 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  The production of superoxide radical during the decomposition of potassium peroxochromate(V).

Authors:  E K Hodgson; I Fridovich
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

3.  A mechanism for the production of ethylene from methional. The generation of the hydroxyl radical by xanthine oxidase.

Authors:  C Beauchamp; I Fridovich
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

4.  Phospholipid precursors of prostaglandins.

Authors:  W E Lands; B Samuelsson
Journal:  Biochim Biophys Acta       Date:  1968-10-22

5.  The possible involvement of singlet oxygen in prostaglandin biosynthesis.

Authors:  A Rahimtula; P J O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1976-06-07       Impact factor: 3.575

6.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

7.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Release of prostaglandins from human polymorphonuclear leukocytes.

Authors:  R B Zurier; D M Sayadoff
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

9.  Lipid peroxidation by human blood phagocytes.

Authors:  T P Stossel; R J Mason; A L Smith
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

Authors:  S Moncada; E A Higgs; J R Vane
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  21 in total

1.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

Review 2.  Hypoxia and inflammatory synovitis: observations and speculation.

Authors:  C R Stevens; R B Williams; A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 3.  Involvement of neutrophils in ischemia-reperfusion injury in the small intestine.

Authors:  H Arndt; P Kubes; D N Granger
Journal:  Klin Wochenschr       Date:  1991-12-15

4.  Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis.

Authors:  G Montosi; C Garuti; A Iannone; A Pietrangelo
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

5.  Oxidative modification of inflammatory synovial fluid immunoglobulin G.

Authors:  H E Jasin
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

6.  Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.

Authors:  M Shingu; M Nobunaga
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

7.  A chemotactic inhibitor in synovial fluid.

Authors:  Y Matzner; R E Partridge; B M Babior
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

8.  Airway inflammation induced by xanthine/xanthine oxidase in guinea pigs.

Authors:  M Misawa; H Arai
Journal:  Agents Actions       Date:  1993-01

9.  Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanol.

Authors:  H D Perez; F J Roll; D M Bissell; S Shak; I M Goldstein
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.

Authors:  L E DeForge; J C Fantone; J S Kenney; D G Remick
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.